Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial
暂无分享，去创建一个
Hao Wang | P. Tran | J. Hearn | C. Deville | T. DeWeese | S. Greco | D. Spratt | E. Davicioni | E. Antonarakis | E. Heath | M. Carducci | S. Denmeade | C. Paller | T. Beer | S. Liauw | M. Markowski | A. Hung | N. Desai | M. Orton | J. Proudfoot | H. Tsai | M. Deek | Steven R. Miller | C. H. Marshall | Tamara Lotan | R. Phillips | Felix Y. Feng | M. Eisenberger | D. Song | Kathryn Lowe | S. Dipasquale | T. Lotan | F. Feng | S. Miller